|Articles|June 15, 2021
Process Development Improvements Post-Pandemic
Author(s)BioPharm International Editors
What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?
Advertisement
In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
